2m 2m 2m 2m 2m 2m 2m
Zoetis-A (ZTS)
NYSE
$73.20+$0.23 (+0.31%)
Price as of Sep 11, 2026 8:00 PM EDT- $30.2BMarket Cap
- -49.82%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Zoetis-A (ZTS)
$73.20+$0.23 (+0.31%)
ZTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $72.97 | ||
Change | +$0.11 (+0.15%) | ||
Open | $73.24 | ||
High | $73.50 | ||
Low | $71.50 | ||
Previous Close | $72.86 | ||
Volume | 5,242,370 | ||
30-Day Average Volume | 4,925,950 | ||
1-Week Change | -3.75% | ||
1-Month Change | -3.16% | ||
1-Year Change | -49.82% | ||
3-Year Change | -59.14% | ||
5-Year Change | -62.71% | ||
Fundamentals | |||
Shares Outstanding | 413.2M | ||
Total Assets | $15.1B | ||
Market Cap | $30.2B | ||
Enterprise Value | $37.7B | ||
Period: QTR TTM FY | |||
Revenue | $2.5B | ||
Net Income | $691.0M | ||
Free Cash Flow | $538.0M | ||
EBIT | $927.0M | ||
EBITDA | $1.0B | ||
Net Working Capital | $4.3B | ||
EPS | $1.65 | ||
Enterprise Value/EBITDA | 36 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 10 | ||
P/E | 44 | ||
PEG | 3 | ||
Price/Free Cash Flow | 56 | ||
Price/Operating Cash Flow | 46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.91% | ||
Trailing Annual Dividend Yield | 2.86% | ||
Ex-Dividend Date | 07/20/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield